University of Minnesota. Driven to Discover.
The proposed law would direct $200 million a year for 5 years to research.
Researchers are relieved to resume experiments, but some public health questions remain.
In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.
The review didn't find any new evidence to drive policy changes, but said more research and new antivirals are needed.
The plan includes a $2.8 billion boost to HHS but cuts to global health.
The budget supports earlier commitment to Gavi vaccine initiatives but dials back funds for other global health efforts.
Experts offer approaches for moving the GOF conundrum forward that are not mutually exclusive, such as lifting the moratorium, seeking international consensus, and establishing a review board.
The NIH sees its biggest boost in 12 years, and other public health initiatives benefit, too.
UW calls a recent UK newspaper story biased and largely wrong.
Clinical trials will test a candidate vaccine for H7N9 flu in varying doses, some with immune boosters.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.